Numbing Agents for Hearing Loss
Trial Summary
What is the purpose of this trial?
Intratympanic steroid injections are an accepted treatment for Meniere's disease and idiopathic sudden sensorineural hearing loss. This treatment is typically performed using local topical anesthesia. There is very limited research on the differences of medications and application procedures effect on patients' pain during the procedure.Topical Tetracaine solution and topical phenol have been shown to be effective as local anesthesia for the tympanic membrane when used for myringotomy. Currently there is no consensus on medication and technique however focally applied phenol is the more widely used technique. We believe this study can provide valuable information given the disadvantages of topical phenol including burning upon application as well as possible increase in persistent tympanic membrane perforation. The objectives are to determine the effectiveness of tetracaine drops for local anesthesia for intratympanic steroid injections compared to focal topical phenol application and to identify if tetracaine drops provides adequate anesthesia for intratympanic steroid injection with less pain on application than focal phenol.
Eligibility Criteria
Adults over 18 with Meniere's disease or sudden sensorineural hearing loss who need intratympanic steroid injections can join. It's not for those under 18, pregnant women, prisoners, people unable to consent in writing, or anyone with a current eardrum perforation.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Phenol 90% concentration (Local Anesthetic)
- Tetracaine 5% drops (Local Anesthetic)